SARS-CoV-2 seroprevalence in Germany - a population based sequential study in five regions

Manuela Harries, Daniela Gornyk, Stephan Glöckner, Monika Strengert, Tobias Kerrinnes, Gerhard Bojara, Stefanie Castell, Kerstin Frank, Knut Gubbe, Jana-Kristin Heise, Pilar Hernandez, Oliver Kappert, Winfried Kern, Thomas Illig, Norman Klopp, Henrike Maaß, Julia Ortmann, Barbora Kessel, Gottfried Roller, Monike Schlüter, Torsten Tonn, Michael Ziemons, Yvonne Kemmling, Berit Lange, Gérard Krause
doi: https://doi.org/10.1101/2021.05.04.21256597

Article Information

doi 
https://doi.org/10.1101/2021.05.04.21256597
History 
  • May 6, 2021.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Manuela Harries1,*,†,
  2. Daniela Gornyk1,13,*,
  3. Dr. Stephan Glöckner1,10,
  4. Dr. Monika Strengert1,11,
  5. Dr. Tobias Kerrinnes2,
  6. Dr. Gerhard Bojara3,
  7. Dr. Stefanie Castell1,
  8. Dr. Kerstin Frank4,
  9. Dr. Knut Gubbe4,
  10. Jana-Kristin Heise1,
  11. Dr. Pilar Hernandez1,
  12. Dr. Oliver Kappert5,
  13. Prof. Dr. Winfried Kern6,
  14. Prof Dr. Thomas Illig7,
  15. Dr. Norman Klopp7,
  16. Henrike Maaß1,
  17. Julia Ortmann1,
  18. Dr. Barbora Kessel1,
  19. Dr. Gottfried Roller8,12,
  20. Monike Schlüter1,
  21. Prof. Dr. Torsten Tonn4,
  22. Dr. Michael Ziemons9,
  23. Dr. Yvonne Kemmling1,
  24. Dr. Berit Lange1,10,# and
  25. Prof. Dr. Gérard Krause1,10,11,#
  1. 1Helmholtz Centre for Infection Research, Department of Epidemiology, Inhoffenstraße 7, 38124 Braunschweig, Germany
  2. 2Helmholtz-Institute for RNA-based Infection Research, Department: RNA-Biology of Bacterial Infections, Josef-Schneider-Str. 2/D15, 97080 Würzburg, Germany
  3. 3Health service for the district and city of Osnabrück, Am Schölerberg 49082 Osnabrück
  4. 4Institute of Transfusion Medicine and Immunohematology, German Red Cross, Plauen, Germany
  5. 5Department of Health and Supply Landratsamt Breisgau-Hochschwarzwald, 79081 Freiburg im Breisgau
  6. 6Infectious Diseases and Travel Medicine, Department of Medicine II, University Hospital Freiburg, University Freiburg
  7. 7Hannover Unified Biobank (HUB), Medizinische Hochschule Hannover (MHH), CRC Hannover, Feodor-Lynen-Str. 15, 30625, Hannover, Germany
  8. 8District Health Department Reutlingen, Sankt-Wolfgang-Straße 13, 72764 Reutlingen, Germany
  9. 9Department of Social Affairs, Health and Digitalization StädteRegion Aachen, Zollernstraße 10, 52070 Aachen, Germany
  10. 10German Center for Infection Research (DZIF), TI BBD, Inhoffenstraße 7, 38124 Braunschweig, Germany
  11. 11TWINCORE, Centre for Experimental and Clinical Research, Feodor Lynen Str 7, 30625 Hannover
  12. 12Baden-Wuerttemberg State Health Office, Nordbahnhofstraße 135, 70191 Stuttgart, Germany
  13. 13PhD Programme Epidemiology Hannover-Braunschweig, Braunschweig, Germany
  1. ↵†Corresponding author:
    Manuela Harries1*, Helmholtz Centre for Infection Research, Department of Epidemiology, Inhoffenstraße 7, 38124 Braunschweig, Germany, E-Mail: Manuela.Harries{at}helmholtz-hzi.de, Phone: +49(0)531-6181-3126

  1. ↵# contributed equally

Back to top
Posted May 06, 2021.
Download PDF

Supplementary Material

Data/Code
Email
SARS-CoV-2 seroprevalence in Germany - a population based sequential study in five regions
Manuela Harries, Daniela Gornyk, Stephan Glöckner, Monika Strengert, Tobias Kerrinnes, Gerhard Bojara, Stefanie Castell, Kerstin Frank, Knut Gubbe, Jana-Kristin Heise, Pilar Hernandez, Oliver Kappert, Winfried Kern, Thomas Illig, Norman Klopp, Henrike Maaß, Julia Ortmann, Barbora Kessel, Gottfried Roller, Monike Schlüter, Torsten Tonn, Michael Ziemons, Yvonne Kemmling, Berit Lange, Gérard Krause
medRxiv 2021.05.04.21256597; doi: https://doi.org/10.1101/2021.05.04.21256597
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area